Recently Viewed
Clear All
IPO Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Bidding Date
20-Feb-2026 to
24-Feb-2026
Issue Size
₹165 Cr
Price Band
₹75 to ₹79
Allotment date
25-Feb-2026
Listing date
27-Feb-2026
Lot size
189
No. of shares
2,08,86,200
Fresh issue/OFS
₹90 Cr/₹75 Cr
Gaudium IVF and Women Health Limited, established in 2009 by Dr. Manika Khanna in Delhi, has expanded from a single fertility clinic into a network of over 30 state-of-the-art centers across six Indian states, evolving to encompass comprehensive women's health services including maternity care alongside its core infertility treatments. The primary focus remains advanced reproductive medicine, offering services such as IVF, IUI, ICSI, blastocyst culture, laser-assisted hatching, surrogacy, and solutions for failed IVF cycles, PCOS, endometriosis, male-factor infertility, and high-risk pregnancies, complemented by laparoscopic surgeries, hysteroscopy, and end-to-end maternity support. Key expertise lies in handling complex cases like recurrent IVF failures, supported by cutting-edge technologies including the INTEGRA Ti system, advanced egg quality evaluation, and WHO/GMP-compliant labs ensuring high success rates. Unique strengths include patient-centric, customized treatment plans, compassionate care, and a referral-center status for challenging infertility scenarios, serving domestic and international patients seeking reliable parenthood solutions. The company's operational philosophy emphasizes science-driven hope, personalized journeys, and ethical practices to address emotional, medical, and accessibility challenges in fertility and women's health.
Category
Status
QIBs
1.6x
NIIs
14.1x
Retail
7.6x
Others
--
Total
7.3x
| Name | Price Band (Rs) | Bidding Date |
|---|---|---|
| Emiac Technologies | 93 - 98 | 27-Mar-2026 to 08-Apr-2026 |
| Safety Controls & Devices | 75 - 80 | 06-Apr-2026 to 08-Apr-2026 |
| Vivid Electromech | 528 - 555 | 25-Mar-2026 to 30-Mar-2026 |
| Amir Chand Jagdish Kumar (Exports) | 201 - 212 | 24-Mar-2026 to 27-Mar-2026 |
The issue size of Gaudium IVF and Women Health is ₹165.00 Cr.
Gaudium IVF and Women Health falls into Healthcare & Services industry.
The Gaudium IVF and Women Health IPO will be listed on both NSE and BSE.
The open and close dates for the Gaudium IVF and Women Health are 20-Feb-2026 & 24-Feb-2026.
The price band for the Gaudium IVF and Women Health ipo is ₹75 to ₹79
The listing date of Gaudium IVF and Women Health IPO is 27-Feb-2026.
The purpose of this IPO is to raise fresh capital as well as enable the existing shareholders to sell their stake.
Gaudium IVF and Women Health total subscription ratio is 7.3X.
Key financial of the Gaudium IVF and Women Health are:
| Gaudium IVF and Women Health | FY-25 | FY-24 | FY-23 |
|---|---|---|---|
| Revenue (₹ Cr) | 70.72 | 47.89 | 44.24 |
| EBIT (₹ Cr) | 26.83 | 17.28 | 18.78 |
| Proft after Tax (₹ Cr) | 19.13 | 10.32 | 13.53 |
| Debt (₹ Cr) | 18.93 | 15.73 | 9.78 |
| Net Worth (₹ Cr) | 46.3 | 26.99 | 22.73 |
| RoE (%) | 41.31 | 38.23 | 59.51 |
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
